Researchers have developed a device that preserves donor eyes outside the body, potentially unlocking whole-eye transplantation. The technology addresses a critical bottleneck in the field: eyes begin degenerating immediately after removal, leaving surgeons a narrow window to perform transplantation before tissue damage becomes irreversible.
The device maintains the eye in a viable state by controlling temperature, oxygen levels, and nutrient delivery. This extends the usable timeframe for transplantation and gives surgeons more flexibility in matching donors with recipients. Previous whole-eye transplant attempts failed partly because the organ deteriorated too quickly, limiting the transplant window to just a few hours.
Whole-eye transplantation has long remained elusive despite advances in other organ transplants. The eye's complexity creates unique challenges. Its delicate neural connections require preservation to restore vision. Early attempts, including a 2014 procedure, resulted in transplanted eyes that could not see, even when the surgery itself succeeded technically. The problem stems from preserving not just the eye's physical structure but also its intricate biological systems.
The preservation device represents a shift toward ex vivo perfusion technology. Similar approaches have shown promise in kidney and liver transplantation, where organs remain functional outside the body under controlled conditions. For eyes, the stakes are even higher because even minor damage to the retina or optic nerve can destroy vision.
The research team tested the device on deceased donor eyes, demonstrating that the organs remained viable for longer periods than conventional preservation methods. The next phase involves actual transplantation trials in human patients.
If successful, the technology could transform eye transplantation from experimental procedure to routine treatment. Vision loss from corneal scarring, keratoconus, and other conditions affects millions globally. Whole-eye transplants offer potential restoration of functional vision rather than just cosmetic improvement.
The work remains in early stages. Surg